Janus Resources, Inc. (OTCQB: JANI), today announced the appointment of Dr. Kenneth Kirkland to the Company’s Board of Advisors. Dr. Kirkland is a seasoned executive from the agricultural chemical industry, having served more than two decades in senior management with Sandoz Inc. and American Cyanamid Company, in both the United States and overseas. He brings specific expertise with product development, in-out licensing, intellectual property and commercialization, from his executive technology transfer positions at Iowa State University, which ranked as America’s leading university for the number of licenses executed during his tenure.

Kenneth Kirkland, M.S., Ph.D. Member, Board of Advisors Janus Resources, Inc. (Photo: Business Wire)

“I welcome Ken to our team and feel his appointment is particularly timely given that our ability to conduct resource exploration activities on the Company’s Fostung tungsten property has been adversely impacted by the current economic and financial environment. I believe that it is prudent, in order to enhance shareholder value, to explore new business opportunities,” explained Janus’ interim President and CEO, Mr. Joseph Sierchio. “Ken’s years of experience and expertise will be of great assistance in our efforts to locate and, if appropriate, acquire a new business opportunity.”

Dr. Kirkland will assist Janus in assessing the commercial viability of new business opportunities extending beyond the Company’s current resource exploration operations. He brings a focused, pragmatic approach to negotiation and the evaluation of the commercial potential of new technologies and prospective acquisition targets. He is able to work effectively with commercial companies and academic institutions in bringing new products and technologies to market.

Dr. Kirkland’s latest appointment was with Iowa State University as Executive Director of the Research Foundation and Director of the Office of Intellectual Property and Technology Transfer. While there, he was successful in increasing the licensing of the University’s technologies to companies to achieve number one ranking among U.S. universities in the number of license executed. Dr. Kirkland also spearheaded successful litigation against infringers of the Research Foundation’s intellectual property resulting in total settlements of $20 million.

Dr. Kenneth Kirkland completed his undergraduate studies in the U.K., and obtained his M.S. and Ph.D. degrees in Agronomic Crop Science from Oregon State University.

About Janus Resources, Inc.

Janus Resources, Inc. is a junior natural resources exploration company. The Company is engaged in the acquisition, exploration and development of mineral exploration properties. The Company’s mineral property exploration activities are located in Canada. The Company currently holds the rights to the Fostung tungsten property, which is comprised of two contiguous claim blocks of 30 claims totaling 485 hectors. The Fostung property is located in Foster Township, Sudbury Mining Division, Ontario, Canada.

For additional information, please call Ms. Briana L. Erickson toll-free at 1-800-755-5815 or visit: http://www.janusresourcesinc.com.

To receive future press releases via email, please visit: http://www.janusresourcesinc.com/projects/

To view the full HTML text of this release, please visit: http://www.janusresourcesinc.com/investors/news-releases/

Disclaimer

No statement herein should be considered an offer or a solicitation of an offer for the purchase or sale of any securities. This news release contains “forward-looking statements”, as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the expectation that the company may enter into any agreements for the acquisition of a new business venture or the business terms of any agreements the company may enter into. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with the search for new business opportunities. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. These reports and filings may be inspected and copied at the Public Reference Room maintained by the U.S. Securities & Exchange Commission at 100 F Street, N.E., Washington, D.C. 20549. You can obtain information about operation of the Public Reference Room by calling the U.S. Securities & Exchange Commission at 1-800-SEC-0330. The U.S. Securities & Exchange Commission also maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the U.S. Securities & Exchange Commission at http://www.sec.gov. The Company undertakes no obligation to publicly release the results of any revisions to these forward looking statements that may be made to reflect the events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

RenovaCare (CE) (USOTC:RCAR)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more RenovaCare (CE) Charts.
RenovaCare (CE) (USOTC:RCAR)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more RenovaCare (CE) Charts.